Paper
25 February 2020 Reactive oxygen species explicit dosimetry for the evaluations of treatment efficiency of single and fractionated ALA-mediated photodynamic therapy
Author Affiliations +
Abstract
Reactive oxygen species explicit dosimetry (ROSED) has been recently developed and demonstrated to be able to better correlate with treatment outcome in both preclinical type I and type II PDT. ROSED involves direct measurements of in-vivo light fluence (rate), in-vivo photosensitizer concentration and tissue oxygenation to calculate for reacted ROS concentration ([ROS]rx) generated by PDT processes. In this study, we demonstrated ROSED in ALA-mediated PDT for mice bearing radiation-induced fibrosacorma (RIF) tumor. PDT treatments were performed using single or fractionated illumination to a same total fluence of 140Jcm-2. The effects of light fractionation on the total reacted [ROS]rx and treatment outcomes were evaluated.
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yi Hong Ong, Tianqi Sheng, Theresa M. Busch, and Timothy C. Zhu "Reactive oxygen species explicit dosimetry for the evaluations of treatment efficiency of single and fractionated ALA-mediated photodynamic therapy", Proc. SPIE 11220, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIX, 112200R (25 February 2020); https://doi.org/10.1117/12.2546425
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Photodynamic therapy

Tumors

Oxygen

Optical testing

In vivo imaging

Fiber coupled lasers

Natural surfaces

Back to Top